Cancer Council New South Wales, Sydney;
Int J Gen Med. 2010 Aug 30;3:225-30. doi: 10.2147/ijgm.s11117.
Traditional scientific review processes are not well suited for evaluating the merits of research in situations where the available scientific evidence is limited and if review panels have widely divergent opinions. This study tested whether a Delphi process is useful in grant selection.
A Delphi process prioritized novel research proposals in pancreatic cancer. Five reviewers holding similar grants overseas ranked research applications by scientific merit, innovativeness, and level of risk.
Three rounds of voting evaluated the best 10 applications received. In the first round of the Delphi process, scores ranged from 5.0 to 8.3. After the second round, the cumulative scores of the eight remaining applications ranged from 10 to 12.6. At the end of the third round, the final cumulative scores of the remaining six applications ranged from 13.6 to 18.2. The four highest ranking applications were recommended for funding, with agreement from reviewers.
A modified Delphi process proved to be an efficient, transparent, and equitable method of reviewing novel grant applications in a specialized field of research, where no local expertise was available. This process may also be useful for other peer review processes, particularly where there is limited access to local experts.
传统的科学评审过程并不适合评估在可用科学证据有限且评审小组意见分歧较大的情况下的研究价值。本研究旨在测试德尔菲法在资助选择中的应用效果。
德尔菲法对胰腺癌的新研究方案进行了优先级排序。五位在海外拥有类似资助的评审员根据科学价值、创新性和风险程度对研究申请进行排名。
三轮投票评估了收到的前 10 个最佳应用程序。在德尔菲法的第一轮投票中,评分范围从 5.0 到 8.3。第二轮投票后,剩余 8 个应用程序的累积得分从 10 到 12.6。在第三轮投票结束时,剩余 6 个应用程序的最终累积得分从 13.6 到 18.2。四个得分最高的申请被推荐获得资助,得到了评审员的一致认可。
经过修改的德尔菲法在一个缺乏本地专业知识的专门研究领域,证明是一种高效、透明和公平的评审新资助申请的方法。该方法也可能适用于其他同行评审过程,特别是在获取本地专家资源有限的情况下。